Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ViaGene Biotech is a biotechnology company focused on the development of innovative gene and cell therapies, primarily targeting oncology and other complex diseases. The company leverages its expertise in viral vector engineering and molecular biology to provide both proprietary therapeutic candidates and specialized contract research services. ViaGene's core capabilities include the design and production of high-quality viral vectors, such as lentivirus and adenovirus, for use in advanced medical research and clinical applications. By integrating cutting-edge genetic engineering with robust manufacturing processes, the company aims to accelerate the transition of gene-based medicines from the laboratory to the clinic.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ViaGene Biotech.